Cullinan Therapeutics Inc (CGEM)
R&D Expense Growth
5.49%
Quarterly · Period ending:
CGEM R&D Expense Growth
Latest reported5.49%period ending
Latest reported5.49%period ending
CGEM Quarterly R&D Growth (QoQ) (0.00% → 5.49%)
Latest values, visible window
High-resolution chart · PNG
CGEM r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 5.4934% | |
| -1.9141% | |
| 2.328% | |
| -31.2338% | |
| 47.2057% | |
| 2.3881% | |
| 14.0427% | |
| -2.0767% | |
| 18.3156% | |
| -12.0581% | |
| 3.0366% | |
| 23.4749% | |
| -47.4221% | |
| 144.3413% | |
| 8.3384% | |
| -25.4856% | |
| 7.6418% | |
| 17.5208% | |
| 64.653% | |
| 7.6583% | |
| -5.1309% | |
| -25.3413% | |
| 67.7494% | |
| -20.6706% | |
| 199.4488% | |
| 9.758% | |
| -27.9378% | |
| 36.8612% | |
| 0% | |
| 0% |